ConfometRx

AstraZeneca and Conformetrix form collaboration

Monday, April 16, 2012

Through a newly-formed research collaboration, Conformetrix, a company focused on optimizing drug discovery and design, will apply its proprietary NMR-based technology across AstraZeneca’s pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.

[Read More]